Tower Research Capital LLC (TRC) - LAVA THERAPEUTICS NV ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of LAVA THERAPEUTICS NV
ValueSharesWeighting
Q3 2023$17,581
-27.6%
11,9600.0%0.00%0.0%
Q2 2023$24,279
+304.6%
11,960
+2047.2%
0.00%
Q2 2021$6,0005570.00%
Other shareholders
LAVA THERAPEUTICS NV shareholders Q4 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 610,809$2,791,0000.94%
Novo Holdings A/S 3,327,312$15,206,0000.72%
Redmile Group, LLC 2,816,196$12,870,0000.50%
Alpha Wave Global, LP 121,193$554,0000.06%
Artal Group S.A. 200,000$914,0000.04%
Cannell Capital 17,955$82,0000.02%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 75,000$343,000,0000.01%
AXA S.A. 457,342$2,090,0260.00%
TSFG, LLC 400$2,0000.00%
OSAIC HOLDINGS, INC. 48$00.00%
View complete list of LAVA THERAPEUTICS NV shareholders